Cryptococcal meningitis in AIDS

Indian Journal of Medical Sciences

Volumn 56, Issue 12, 2002, Pages 593-597

  Iyer, Revathi S ^a   Banker, D D ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; AMPHOTERICIN B; FLUCONAZOLE; ITRACONAZOLE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CRYPTOCOCCOSIS; CRYPTOCOCCUS; FUNGUS CULTURE; FUNGUS ISOLATION; INCIDENCE; INFECTION SENSITIVITY; MYCOTIC MENINGITIS; POLYMERASE CHAIN REACTION; ADULT; AIDS RELATED COMPLEX; CEREBROSPINAL FLUID; CLINICAL TRIAL; CRYPTOCOCCAL MENINGITIS; CRYPTOCOCCUS NEOFORMANS; DRUG EFFECT; GENETICS; HUMAN; ISOLATION AND PURIFICATION; METHODOLOGY; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MIDDLE AGED; TREATMENT OUTCOME;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; AMPHOTERICIN B; ANTIBIOTICS, ANTIFUNGAL; ANTIFUNGAL AGENTS; CRYPTOCOCCUS NEOFORMANS; FLUCONAZOLE; HUMANS; ITRACONAZOLE; MENINGITIS, CRYPTOCOCCAL; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; POLYMERASE CHAIN REACTION; TREATMENT OUTCOME;

EID: 0142135414     PISSN: 00195359     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Deodhar L. Immunological diagnosis of cryptococcal meningitis in Human Immunodeficiency Virus infected patients. Indian J Med Microbiol. 2000; 18: 85.
2. Powderty WG. Cryptococcosis: First in a six - part series on Fungal infections, In The Website of The International Association of Physicians in AIDS Care (IAPAC). From JIAPAC, July, 1996 (Obtained on the Internet).
3. Rippon JW. Medical Mycology: The pathogenic fungi and the pathogenic actinomycetes. pp 795. Philadelphia. WB Saunders Co. 1982.
4. Reference method for broth dilution antifungal susceptibility testing of yeasts: Approved standard. M27 - A. NCCLS. 1997;17: 1-29.
5. Walsh TJ, Francesconi A, Kasai M, Chanock SJ. PCR and single-strand conformational polymorphism for recognition of medically important opportunistic fungi. J Clin Microbiol. 1995; 33: 3216-20.
6. Stansell JD. Pulmonary fungal infections in HIV infected persons. Semin Resp Infect. 1993; 8: 116-23.
7. Warnock DW. The role of laboratory in the diagnosis of fungal infection. Proceedings of Mycology - 2000. 15. Mumbai. 2000.
8. Kwon - Drung KJ, Bennette JE. Medical Mycology. 396-439. London. Lea & Febiger. 1992.
9. Lindsley MD, Hurst SF, Iqbal NJ, Morrison CJ. Rapid identification of dimorphic and yeast - like fungal pathogens using specific DNA probes. J Clin Microbiol 2001; 39: 3505-11.
10. Rapelli P, Are R, Casu G, Fiori PL, Capuccinelli P, Aceti A. Development of a nested PCR for detection of Cryptococcus neoformans in CSF. J Clin Microbiol 1998; 36: 3438-40.
11. Iyer RS, Pal RB, Patel RY, Banker DD. Polymerase chain based diagnosis of systemic fungal infections and sensitivity testing of the fungal isolates. Indian J Med Microbiol. 2002; 20: 132-36.
12. Davey KJ, Holmes AD, Johnson EM, Szekeley A, Warnock DW. Cooperative evaluation of FUNGITEST and broth microdilution methods for antifungal drug susceptibility testing of Candida species and Cryptococcus neoformans. J Clin Microbiol. 1998; 36:926-30.
13. Gordon MA, Lapa EW, Passeo PG. Improved method for azole antifungal susceptibility testing, J Clin Microbiol. 1998; 26: 1874-77.
14. Shadomy S, Espinel-Ingroff A, Gebhart RJ. In vitro studies with SF 86-327, a new orally active allylamine derivative. J Med Vet Mycol. 1985; 23: 125-32.